Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,196 | 1,171 | 80.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,680 | 1 | 15.4% |
| Education | $1,022 | 13 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ortho Dermatologics, a division of Bausch Health US, LLC | $4,044 | 26 | $0 (2024) |
| Janssen Biotech, Inc. | $3,890 | 239 | $0 (2024) |
| ABBVIE INC. | $3,073 | 181 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,420 | 149 | $0 (2024) |
| Lilly USA, LLC | $1,255 | 58 | $0 (2024) |
| UCB, Inc. | $1,172 | 70 | $0 (2024) |
| GENZYME CORPORATION | $859.57 | 35 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $848.56 | 43 | $0 (2024) |
| Amgen Inc. | $755.19 | 27 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $753.90 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,621 | 222 | Janssen Biotech, Inc. ($760.84) |
| 2023 | $3,372 | 194 | Janssen Biotech, Inc. ($687.99) |
| 2022 | $3,238 | 196 | Janssen Biotech, Inc. ($964.00) |
| 2021 | $2,357 | 131 | Janssen Biotech, Inc. ($508.76) |
| 2020 | $1,269 | 75 | AbbVie Inc. ($272.91) |
| 2019 | $5,491 | 114 | Ortho Dermatologics, a division of Bausch Health US, LLC ($3,729) |
| 2018 | $1,886 | 125 | Janssen Biotech, Inc. ($250.71) |
| 2017 | $2,664 | 128 | AbbVie, Inc. ($281.61) |
All Payment Transactions
1,185 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.64 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $8.00 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.30 | General |
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.89 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.11 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,329 | 2,483 | $131,915 | $64,069 |
| 2022 | 8 | 1,791 | 3,113 | $181,280 | $92,157 |
| 2021 | 9 | 1,852 | 3,243 | $187,610 | $95,985 |
| 2020 | 8 | 1,881 | 3,440 | $198,565 | $87,640 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 505 | 558 | $50,220 | $30,537 | 60.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 314 | 362 | $36,200 | $14,473 | 40.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 187 | 202 | $11,110 | $6,760 | 60.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 228 | 1,263 | $18,945 | $5,452 | 28.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 26 | 28 | $6,440 | $3,185 | 49.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 28 | 29 | $4,350 | $1,688 | 38.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $3,120 | $1,461 | 46.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 17 | 17 | $1,530 | $513.03 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 667 | 760 | $68,400 | $42,763 | 62.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 420 | 492 | $49,200 | $20,780 | 42.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 208 | 233 | $12,815 | $8,526 | 66.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 294 | 1,421 | $21,315 | $6,441 | 30.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 40 | 43 | $9,890 | $4,668 | 47.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 53 | 55 | $8,250 | $3,552 | 43.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 69 | 69 | $6,210 | $2,971 | 47.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 40 | 40 | $5,200 | $2,455 | 47.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 685 | 776 | $69,840 | $44,973 | 64.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 424 | 506 | $50,600 | $20,213 | 39.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 208 | 232 | $12,760 | $9,069 | 71.1% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 325 | 1,512 | $22,680 | $6,356 | 28.0% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 41 | 45 | $10,350 | $5,193 | 50.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 64 | 65 | $9,750 | $4,188 | 43.0% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 65 | 65 | $5,850 | $3,176 | 54.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 26 | 26 | $3,380 | $2,202 | 65.1% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 14 | 16 | $2,400 | $614.72 | 25.6% |
About Dr. David Altman, M.D
Dr. David Altman, M.D is a Dermatology healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598764433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Altman, M.D has received a total of $23,899 in payments from pharmaceutical and medical device companies, with $3,621 received in 2024. These payments were reported across 1,185 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($19,196).
As a Medicare-enrolled provider, Altman has provided services to 6,853 Medicare beneficiaries, totaling 12,279 services with total Medicare billing of $339,851. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Williamsville, NY
- Active Since 07/21/2005
- Last Updated 07/28/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1598764433
Products in Payments
- SILIQ (Drug) $3,902
- TREMFYA (Drug) $2,270
- SKYRIZI (Biological) $1,494
- DUPIXENT (Biological) $1,444
- TALTZ (Drug) $1,132
- Otezla (Drug) $1,065
- COSENTYX (Biological) $894.76
- REMICADE (Biological) $834.00
- Cimzia (Drug) $811.30
- Humira (Biological) $747.42
- OPZELURA (Drug) $674.54
- EUCRISA (Drug) $591.95
- Tremfya (Drug) $586.41
- RINVOQ (Biological) $521.77
- Sotyktu (Drug) $503.20
- COSENTYX (Drug) $428.07
- ENSTILAR (Drug) $351.00
- Bimzelx (Biological) $330.70
- STELARA (Biological) $324.64
- ILUMYA (Biological) $318.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Williamsville
Dr. Michael Nazareth, M.d./Ph.d, M.D./PH.D
Dermatology — Payments: $800,700
Dr. Robert Kalb, Md, MD
Dermatology — Payments: $150,681
Dr. Animesh Sinha, M.d, M.D
Dermatology — Payments: $10,537
Zoey Glick, M.d. As Of 5/17/09, M.D. AS OF 5/17/09
Dermatology — Payments: $8,249
Tara Paolini, Md, MD
Dermatology — Payments: $7,501
Melissa Sicurella
Dermatology — Payments: $3,686